Steroid activities comparison of natural and food wrap compounds in human breast cancer cell lines.
In this study, we tested and compared the endocrine disruption activities of compounds in materials used to package foods (bisphenol A, bisphenol F, and bisphenol A diglycidylether BADGE) with natural molecules (genistein, apigenin, kaempferol, and tangeretin) in the human breast cancer cell lines MCF-7 (ER(+)) and MDA-MB453 (AR(+); GR(+)). Octylphenol was also chosen as a xenoestrogen reference. Two compounds had no estrogenic activity: BADGE and tangeretin. Genistein was the most active compound in the E-Screen assay with MCF-7, followed by octylphenol, bisphenol F, bisphenol A and apigenin, with kaempferol the least potent. All estrogenic compounds competed with 17beta-estradiol for binding to the MCF-7 ER and their estrogenic effects were abolished in the presence of tamoxifen, an ER antagonist. In MDA-MB453 cells transfected with pMMTVneo-Luc, all compounds had anti-androgenic activities, with octylphenol the most potent. Kaempferol, genistein, and apigenin were more potent anti-androgens than bisphenols A or F. The natural compounds had a biphasic effect on luciferase activity. At high concentrations, genistein (10(-5)M) and apigenin (10(-6)M) acted as GR agonists in transfected MDA-MB453 cells. Furthermore, apigenin, at a concentration of 10(-5)M, may act as a partial androgen receptor (AR) agonist, as nilutamide, an AR antagonist, inhibited its activity by 26%.
Stroheker
T
T
UMR 1234 Toxicologie Alimentaire, University of Burgundy/INRA, 1 Esplanade Erasme, 21000 Dijon, France.
Picard
K
K
Lhuguenot
J C
JC
Canivenc-Lavier
M C
MC
Chagnon
M C
MC
D016588:Anticarcinogenic Agents / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology; D047310:Apigenin; D001559:Benzhydryl Compounds; D001943:Breast Neoplasms / Q000473:pathology*; D002273:Carcinogens / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004703:Endocrine System / Q000187:drug effects; D004852:Epoxy Compounds / Q000494:pharmacology; D004968:Estrogens, Non-Steroidal / Q000494:pharmacology; D005260:Female; D047309:Flavones; D005419:Flavonoids / Q000494:pharmacology; D018857:Food Packaging; D019833:Genistein / Q000494:pharmacology; D006801:Humans; D044949:Kaempferols / Q000494:pharmacology; D010636:Phenols / Q000494:pharmacology; D011944:Receptors, Androgen / Q000187:drug effects* / Q000502:physiology; D011960:Receptors, Estrogen / Q000187:drug effects*; D014407:Tumor Cells, Cultured; D000098826:Bisphenol A Compounds
D016588:Anticarcinogenic Agents; D000970:Antineoplastic Agents; D047310:Apigenin; D001559:Benzhydryl Compounds; D002273:Carcinogens; D004852:Epoxy Compounds; D004968:Estrogens, Non-Steroidal; D047309:Flavones; D005419:Flavonoids; D019833:Genistein; D044949:Kaempferols; D010636:Phenols; D011944:Receptors, Androgen; D011960:Receptors, Estrogen; C006552:kaempferol; C019273:bisphenol A diglycidyl ether; D000098826:Bisphenol A Compounds; C059006:tangeretin; C006780:bisphenol A; C423722:bisphenol F diglycidyl ether